Director sold ~$228K of ResMed|
Scheduled in advanceLoading…
Traded Aug 5, 2026 · Filed Aug 6, 2026
A board member of ResMed| sold $1.8M of ResMed| shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,800,000
Shares × reported transaction price
29 days after results of Jul 7, 2026, 1 day before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $224.03 on Aug 5, 2026, 23% above its 52-week low and 24% below its high, after a 17% rise over the previous 30 trading days
52-week range $182.82 (Jun 2, 2026) to $293.73 (Aug 22, 2025), 37% of the way up, from 251 adjusted closes. 30 trading days earlier: $191.26 on Jun 23, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.9% | +0.4% | +5.5% |
| 30 days | +4.3% | -0.9% | +5.2% |
Past results only. Not a forecast.
Director sold ~$228K of ResMed|
Scheduled in advanceDirector plans to sell ~$228K of ResMed|
Planned, from payFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.